These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial. Bondar J; Caye A; Chekroud AM; Kieling C Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509 [TBL] [Abstract][Full Text] [Related]
63. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. Walkup JT; Albano AM; Piacentini J; Birmaher B; Compton SN; Sherrill JT; Ginsburg GS; Rynn MA; McCracken J; Waslick B; Iyengar S; March JS; Kendall PC N Engl J Med; 2008 Dec; 359(26):2753-66. PubMed ID: 18974308 [TBL] [Abstract][Full Text] [Related]
64. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. Silverstone PH; Salinas E J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362 [TBL] [Abstract][Full Text] [Related]
65. Selective serotonin reuptake inhibitors in mixed anxiety-depression. Berk M Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S41-5. PubMed ID: 11110018 [TBL] [Abstract][Full Text] [Related]
66. Are paroxetine, fluoxetine, and sertraline equally effective for depression? Straton JB; Cronholm P J Fam Pract; 2002 Mar; 51(3):285. PubMed ID: 11978244 [No Abstract] [Full Text] [Related]
67. Depression in children and adolescents. Hazell P Clin Evid; 2004 Dec; (12):427-42. PubMed ID: 15865648 [No Abstract] [Full Text] [Related]
68. Care of depressed patients with anxiety symptoms. Nutt DJ J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738 [TBL] [Abstract][Full Text] [Related]
69. Emotion-based brain mechanisms and predictors for SSRI and CBT treatment of anxiety and depression: a randomized trial. Gorka SM; Young CB; Klumpp H; Kennedy AE; Francis J; Ajilore O; Langenecker SA; Shankman SA; Craske MG; Stein MB; Phan KL Neuropsychopharmacology; 2019 Aug; 44(9):1639-1648. PubMed ID: 31060042 [TBL] [Abstract][Full Text] [Related]
70. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. Asarnow JR; Emslie G; Clarke G; Wagner KD; Spirito A; Vitiello B; Iyengar S; Shamseddeen W; Ritz L; Birmaher B; Ryan N; Kennard B; Mayes T; DeBar L; McCracken J; Strober M; Suddath R; Leonard H; Porta G; Keller M; Brent D J Am Acad Child Adolesc Psychiatry; 2009 Mar; 48(3):330-339. PubMed ID: 19182688 [TBL] [Abstract][Full Text] [Related]
77. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders. Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135 [TBL] [Abstract][Full Text] [Related]
78. Use of SSRIs in children. Bienert SE J Fam Pract; 1998 Feb; 46(2):118. PubMed ID: 9487315 [No Abstract] [Full Text] [Related]
79. Commentary: Putting research into practice. Gale C BMJ; 2003 Mar; 326(7391):700-2; discussion 700-2. PubMed ID: 12664889 [No Abstract] [Full Text] [Related]
80. Psychopharmacology in the New York Times. Kramer TA MedGenMed; 2004 Jun; 6(2):26. PubMed ID: 15266252 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]